Mumbai: Alembic Pharmaceuticals Limited has received the Establishment Inspection Report (EIR) for the inspection conducted by the US Food and Drug Administration (USFDA) at its API-I and API-II facilities in Panelav. The inspection was carried out between May 26, 2025 and May 31, 2025.
Alembic Pharmaceuticals Limited receives Establishment Inspection Report (EIR) for its API – I & API – II Facility located at Panelav.
Uploaded On
by
Company profile
Konexio Network
Konexio Network helps our society with the daily business news updates, Corporate Interview, Article on Market and General Article which help our readers.
Leave a Reply